13F

Stock

Biocryst Pharmaceuticals Inc

BCRX · held by 4 managers

Reported value

$7.67M

Holders

4

+0 new · −0 exited

Holders’ est. mark

$652.3K

Price effect on 3 books still in the name

Largest holder

$7.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC804.1K$7.2M$587.8KAdded$4.19M
Sanctuary Advisors, LLC44.2K$395.7K$63.5KAdded$69.3K
Essential Partners LLC6.54K$58.6KHeld
DANSKE BANK A/S700$6.27K$1.02KCut−$1.45M

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.